PAVmed Inc. — Director's Dealing 2019

Feb 4, 2019

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2018-12-31

Reporting Person: MCGRATH DENNIS M (EVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-12	Common Stock	X	12000	—	Acquired	24000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-12	Series Z Warrants	$1.60	X	12000	Acquired	2024-04-30	Common Stock (12000)	Direct
2018-06-12	Subscription Rights (Right to Buy)	$1.15	X	12000	Disposed	2018-06-12	Units (1 share of Common Stock and 1 Series Z Warrant) (12000)	Direct

Footnotes

F1: The reporting person purchased units from the issuer in the issuer's equity rights offering, each unit consisting of one share of the issuer's common stock and one Series Z Warrant, at a price of $1.15 per unit.